Viria Sold Part of Its Shares in DNA

Viria Plc has sold a third of its shares in DNA. The selling price was approximately EUR 16 million, which resulted in a profit from sales of EUR 12.3 million for Viria.
“The DNA shares have gone up in price in the last year and we wanted to utilise that by selling part of our quite extensive shareholding in DNA. Selling the shares is also well-founded from the point of view of spreading the risks. Even after selling these shares Viria remains one of the largest owners of DNA, and we don’t intend to sell more shares at this stage”, says Mika Vihervuori, CEO of Viria Plc.
Viria intends to use the sales profit from selling the shares to increase its business. “In the next few years, we are aiming for strong growth, both organically and through acquisitions supporting our strategy, and in this way, we intend to develop the value of the company for our owners”, says Vihervuori.
More information
Mika Vihervuori, CEO, tel. 040 720 2140

Loihde Advance Oy is born on 1.6.2023

Our subsidiaries Loihde Analytics and Loihde Advisory have been operating under Loihde Advance name since the beginning of 2023. The merger of the two companies will now be completed when…